SAN DIEGO, Nov. 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabiscompany in the United States, announced today that its subsidiary HempMeds® Mexico has received five new permits from the Mexican Federal Commission for Protection Against Sanitary
"We are glad to continue to be a pioneer in this important growing industry and are excited to expand our market reach to a new group of active consumers," said HempMeds® Mexico President Raul Elizalde. "This will provide our company with the opportunity to provide premium CBD-based products to a much broader customer base in Mexico."
The new portfolio of Real Scientific Hemp Oil™ (RSHO™) products that HempMeds® Mexico will be approved to import includes:
"Our international authority continues to flourish with these new permits and we couldn't be prouder to have such an influential presence in the Mexican market," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We hope that consumers will see that we are dedicated to providing them with as many options as possible so that they can decide how CBD best fits into their everyday lives."
About HempMeds® MexicoHempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexicoplans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx.
About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:
Andrew HardChief Executive OfficerCMW MediaP. firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/mexicos-cofepris-grants-five-new-cannabis-import-permits-to-medical-marijuana-inc-subsidiary-hempmeds-mexico-300754577.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!